ImCheck Therapeutics is a clinical-stage biotechnology company focused on developing immunotherapies that modulate innate immune checkpoints to treat cancer. The company advances antibody-based therapeutic programs designed to activate or reprogram innate immune cells and to be used alone or in combination with established oncology treatments. ImCheck also integrates translational biomarker strategies to inform patient selection and clinical development.
Leadership & Board
Current Number of Employees44
Current LinkedIn Followers11,797
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$22M
Total Amount Raised$22M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$22M
Latest Funding Amount$22M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
ImCheck Therapeutics had 44 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
44Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
ImCheck Therapeutics had 11,797 followers as of September 28, 2026. The number of followers increased by 14 (0.12%) week-over-week.
11,797Latest Followers Count
14(0.12%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.